HORIZON DISCOVERY LIMITED - United Kingdom 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 2.924.526 0 1
2013 0 5.995.449 240.179 1
2012 0 7.461.716 675.240 1
2011 0 23.822.712 1.471.370 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
VTT TECHNICAL RESEARCH CENTRE OF FINLAND2
4SC DISCOVERY1
ACCELOPMENT SCHWEIZ1
ACIES SAS1
AGENDIA NV1
ARTTIC IN BRUSSELS SPRL1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION POUR LA RECHERCHE DE THERAPEUTIQUES INNOVANTES EN CANCEROLOGIE1
AVECTAS LIMITED1
AXXAM1
AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA1
BAYER PHARMA1
BECTON DICKINSON RESEARCH CENTRE IRELAND LIMITED1
BIOCEROS BV1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CANCER RESEARCH UK1
CELLARTIS AB1
CLC BIO1
CLINICAL GENE NETWORKS AB1
COBRA BIOPHARMA MATFORS AB1
DANMARKS TEKNISKE UNIVERSITET1
DEUTSCHES HERZZENTRUM MUNCHEN1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN SCREENINGPORT1
EXPERIMENTAL PHARMACOLOGY AND ONCOLOGY BERLINBUCH1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
GENEDATA1
GENOME RESEARCH1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
HELLENIC CENTRE FOR MARINE RESEARCH1
ICELANDIC FISHERIES LABORATORIES1
INGENZA LIMITED1
INSTITUT GUSTAVE ROUSSY1
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA1
ISTITUTO EUROPEO DI ONCOLOGIA1
JULIUSMAXIMILIANS UNIVERSITAET WUERZBURG1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KUNGLIGA TEKNISKA HOEGSKOLAN1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUNDS UNIVERSITET1
MARINE BIOPOLYMERS LIMITED1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEIRAGTX UK II1
NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED1
NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN1
NOVAMEN SAS1
PHARMAQ AS1
PROKAZYME EHF1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
SEMMELWEIS EGYETEM1
SPIBER TECHNOLOGIES AB1
STICHTING KATHOLIEKE UNIVERSITEIT1
SWISS INSTITUTE OF BIOINFORMATICS1
TECHNISCHE UNIVERSITAET DARMSTADT1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE ROYAL MARSDEN NATIONAL HEALTH SERVICE TRUST1
THE SCOTTISH ASSOCIATION FOR MARINE SCIENCE1
THE UNIVERSITY OF LIVERPOOL1
TILT BIOTHERAPEUTICS OY1
UNIVERSIDADE NOVA DE LISBOA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITAET ZU LUEBECK1
UNIVERSITEIT ANTWERPEN1
UNIVERSITY COLLEGE DUBLIN1
UNIVERSITY OF COPENHAGEN1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF LEICESTER1
UNIVERSITY OF STRATHCLYDE1

Constancy:

Total number of partners: 76
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 76
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysis STACCATOparticipant2.924.52616
2013-10-01Exploitation of genomic variants affecting coronary artery disease and stroke risk for therapeutic intervention CVGENES-AT-TARGETparticipant5.995.44912
2012-08-01From sea-bed to test-bed: harvesting the potential of marine microbes for industrial biotechnology SeaBioTechparticipant7.461.71616
2011-12-01Developing a global understanding of the PRC and NuRD complexes in stem cell differentiation, in health and disease 4DCELLFATEparticipant11.982.40313
2011-01-01Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics PREDICTparticipant5.841.00914
2011-01-01Modelling and predicting sensitivity to targeted therapies in colorectal cancers COLTHERESparticipant5.999.30011